0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Locked Nucleic Acids (LNA) Market Research Report 2026
Published Date: 2026-01-23
|
Report Code: QYRE-Auto-37O18623
Home | Market Reports | Science| Biological Sciences
Global Locked Nucleic Acids LNA Market Research Report 2024
BUY CHAPTERS

Global Locked Nucleic Acids (LNA) Market Research Report 2026

Code: QYRE-Auto-37O18623
Report
2026-01-23
Pages:147
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Locked Nucleic Acids (LNA) Market Size

The global Locked Nucleic Acids (LNA) market was valued at US$ 2053 million in 2025 and is anticipated to reach US$ 3474 million by 2032, at a CAGR of 7.9% from 2026 to 2032.

Locked Nucleic Acids (LNA) Market

Locked Nucleic Acids (LNA) Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Locked Nucleic Acids (LNA) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Locked Nucleic Acids (LNA) were first independently described in 1997 by Jesper Wengel1 and Takeshi Imanishi2 and have become an important part of hybridisation-based applications.LNAs are a class of modified RNA-nucleic acid analogues that have an additional methylene bridge. This linkage connects the oxygen atom at the C-2´ of the ribose with the 4´-carbon atom and helps to fix the ribose ring in the 3'-endo conformation (""locked"") which leads to the characteristic A-RNA structure and to the exclusive formation of
A-duplexes.
The North American market for Locked Nucleic Acids (LNA) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Locked Nucleic Acids (LNA) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Locked Nucleic Acids (LNA) include Ajinomoto Bio-Pharma, Medtide Inc., BOC Sciences, QIAGEN, LGC Group, Kaneka Eurogentec SA (Eurogentec), biomers.net GmbH, Ella Biotech GmbH, Eurofins Genomics LLC, Azenta Life Sciences, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Locked Nucleic Acids (LNA) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Locked Nucleic Acids (LNA). The Locked Nucleic Acids (LNA) market size, estimates, and forecasts are provided in terms of shipments (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Locked Nucleic Acids (LNA) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Locked Nucleic Acids (LNA) manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Locked Nucleic Acids (LNA) Market Report

Report Metric Details
Report Name Locked Nucleic Acids (LNA) Market
Accounted market size in 2025 US$ 2053 million
Forecasted market size in 2032 US$ 3474 million
CAGR 7.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • High Affinity LNA
  • Adjustable LNA
by Application
  • Basic research
  • Clinical diagnosis
  • Drug development
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Ajinomoto Bio-Pharma, Medtide Inc., BOC Sciences, QIAGEN, LGC Group, Kaneka Eurogentec SA (Eurogentec), biomers.net GmbH, Ella Biotech GmbH, Eurofins Genomics LLC, Azenta Life Sciences, SHIKOKURIKA CO.,LTD, SBS Genetech, Zhscience, Blossom Biotechnologies Inc., Genecfps, GenScript, RIBO Pharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Locked Nucleic Acids (LNA) manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
  • Chapter 3: Examines Locked Nucleic Acids (LNA) production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
  • Chapter 4: Analyzes Locked Nucleic Acids (LNA) consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
  • Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 10: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Locked Nucleic Acids (LNA) Market growing?

Ans: The Locked Nucleic Acids (LNA) Market witnessing a CAGR of 7.9% during the forecast period 2026-2032.

What is the Locked Nucleic Acids (LNA) Market size in 2032?

Ans: The Locked Nucleic Acids (LNA) Market size in 2032 will be US$ 3474 million.

Who are the main players in the Locked Nucleic Acids (LNA) Market report?

Ans: The main players in the Locked Nucleic Acids (LNA) Market are Ajinomoto Bio-Pharma, Medtide Inc., BOC Sciences, QIAGEN, LGC Group, Kaneka Eurogentec SA (Eurogentec), biomers.net GmbH, Ella Biotech GmbH, Eurofins Genomics LLC, Azenta Life Sciences, SHIKOKURIKA CO.,LTD, SBS Genetech, Zhscience, Blossom Biotechnologies Inc., Genecfps, GenScript, RIBO Pharm

What are the Application segmentation covered in the Locked Nucleic Acids (LNA) Market report?

Ans: The Applications covered in the Locked Nucleic Acids (LNA) Market report are Basic research, Clinical diagnosis, Drug development

What are the Type segmentation covered in the Locked Nucleic Acids (LNA) Market report?

Ans: The Types covered in the Locked Nucleic Acids (LNA) Market report are High Affinity LNA, Adjustable LNA

1 Locked Nucleic Acids (LNA) Market Overview
1.1 Product Definition
1.2 Locked Nucleic Acids (LNA) by Type
1.2.1 Global Locked Nucleic Acids (LNA) Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 High Affinity LNA
1.2.3 Adjustable LNA
1.3 Locked Nucleic Acids (LNA) by Application
1.3.1 Global Locked Nucleic Acids (LNA) Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Basic research
1.3.3 Clinical diagnosis
1.3.4 Drug development
1.4 Global Market Growth Prospects
1.4.1 Global Locked Nucleic Acids (LNA) Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Locked Nucleic Acids (LNA) Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Locked Nucleic Acids (LNA) Production Estimates and Forecasts (2021–2032)
1.4.4 Global Locked Nucleic Acids (LNA) Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Locked Nucleic Acids (LNA) Production Market Share by Manufacturers (2021–2026)
2.2 Global Locked Nucleic Acids (LNA) Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Locked Nucleic Acids (LNA), Industry Ranking, 2024 vs 2025
2.4 Global Locked Nucleic Acids (LNA) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Locked Nucleic Acids (LNA) Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Locked Nucleic Acids (LNA), Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Locked Nucleic Acids (LNA), Product Offerings and Applications
2.8 Global Key Manufacturers of Locked Nucleic Acids (LNA), Date of Entry into the Industry
2.9 Locked Nucleic Acids (LNA) Market Competitive Situation and Trends
2.9.1 Locked Nucleic Acids (LNA) Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Locked Nucleic Acids (LNA) Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Locked Nucleic Acids (LNA) Production by Region
3.1 Global Locked Nucleic Acids (LNA) Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Locked Nucleic Acids (LNA) Production Value by Region (2021–2032)
3.2.1 Global Locked Nucleic Acids (LNA) Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Locked Nucleic Acids (LNA) by Region (2027–2032)
3.3 Global Locked Nucleic Acids (LNA) Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Locked Nucleic Acids (LNA) Production Volume by Region (2021–2032)
3.4.1 Global Locked Nucleic Acids (LNA) Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Locked Nucleic Acids (LNA) by Region (2027–2032)
3.5 Global Locked Nucleic Acids (LNA) Market Price Analysis by Region (2021–2026)
3.6 Global Locked Nucleic Acids (LNA) Production, Value, and Year-over-Year Growth
3.6.1 North America Locked Nucleic Acids (LNA) Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Locked Nucleic Acids (LNA) Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Locked Nucleic Acids (LNA) Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Locked Nucleic Acids (LNA) Production Value Estimates and Forecasts (2021–2032)
4 Locked Nucleic Acids (LNA) Consumption by Region
4.1 Global Locked Nucleic Acids (LNA) Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Locked Nucleic Acids (LNA) Consumption by Region (2021–2032)
4.2.1 Global Locked Nucleic Acids (LNA) Consumption by Region (2021–2026)
4.2.2 Global Locked Nucleic Acids (LNA) Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Locked Nucleic Acids (LNA) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Locked Nucleic Acids (LNA) Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Locked Nucleic Acids (LNA) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Locked Nucleic Acids (LNA) Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Locked Nucleic Acids (LNA) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Locked Nucleic Acids (LNA) Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Locked Nucleic Acids (LNA) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Locked Nucleic Acids (LNA) Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Locked Nucleic Acids (LNA) Production by Type (2021–2032)
5.1.1 Global Locked Nucleic Acids (LNA) Production by Type (2021–2026)
5.1.2 Global Locked Nucleic Acids (LNA) Production by Type (2027–2032)
5.1.3 Global Locked Nucleic Acids (LNA) Production Market Share by Type (2021–2032)
5.2 Global Locked Nucleic Acids (LNA) Production Value by Type (2021–2032)
5.2.1 Global Locked Nucleic Acids (LNA) Production Value by Type (2021–2026)
5.2.2 Global Locked Nucleic Acids (LNA) Production Value by Type (2027–2032)
5.2.3 Global Locked Nucleic Acids (LNA) Production Value Market Share by Type (2021–2032)
5.3 Global Locked Nucleic Acids (LNA) Price by Type (2021–2032)
6 Segment by Application
6.1 Global Locked Nucleic Acids (LNA) Production by Application (2021–2032)
6.1.1 Global Locked Nucleic Acids (LNA) Production by Application (2021–2026)
6.1.2 Global Locked Nucleic Acids (LNA) Production by Application (2027–2032)
6.1.3 Global Locked Nucleic Acids (LNA) Production Market Share by Application (2021–2032)
6.2 Global Locked Nucleic Acids (LNA) Production Value by Application (2021–2032)
6.2.1 Global Locked Nucleic Acids (LNA) Production Value by Application (2021–2026)
6.2.2 Global Locked Nucleic Acids (LNA) Production Value by Application (2027–2032)
6.2.3 Global Locked Nucleic Acids (LNA) Production Value Market Share by Application (2021–2032)
6.3 Global Locked Nucleic Acids (LNA) Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Ajinomoto Bio-Pharma
7.1.1 Ajinomoto Bio-Pharma Locked Nucleic Acids (LNA) Company Information
7.1.2 Ajinomoto Bio-Pharma Locked Nucleic Acids (LNA) Product Portfolio
7.1.3 Ajinomoto Bio-Pharma Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Ajinomoto Bio-Pharma Main Business and Markets Served
7.1.5 Ajinomoto Bio-Pharma Recent Developments/Updates
7.2 Medtide Inc.
7.2.1 Medtide Inc. Locked Nucleic Acids (LNA) Company Information
7.2.2 Medtide Inc. Locked Nucleic Acids (LNA) Product Portfolio
7.2.3 Medtide Inc. Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Medtide Inc. Main Business and Markets Served
7.2.5 Medtide Inc. Recent Developments/Updates
7.3 BOC Sciences
7.3.1 BOC Sciences Locked Nucleic Acids (LNA) Company Information
7.3.2 BOC Sciences Locked Nucleic Acids (LNA) Product Portfolio
7.3.3 BOC Sciences Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 BOC Sciences Main Business and Markets Served
7.3.5 BOC Sciences Recent Developments/Updates
7.4 QIAGEN
7.4.1 QIAGEN Locked Nucleic Acids (LNA) Company Information
7.4.2 QIAGEN Locked Nucleic Acids (LNA) Product Portfolio
7.4.3 QIAGEN Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 QIAGEN Main Business and Markets Served
7.4.5 QIAGEN Recent Developments/Updates
7.5 LGC Group
7.5.1 LGC Group Locked Nucleic Acids (LNA) Company Information
7.5.2 LGC Group Locked Nucleic Acids (LNA) Product Portfolio
7.5.3 LGC Group Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 LGC Group Main Business and Markets Served
7.5.5 LGC Group Recent Developments/Updates
7.6 Kaneka Eurogentec SA (Eurogentec)
7.6.1 Kaneka Eurogentec SA (Eurogentec) Locked Nucleic Acids (LNA) Company Information
7.6.2 Kaneka Eurogentec SA (Eurogentec) Locked Nucleic Acids (LNA) Product Portfolio
7.6.3 Kaneka Eurogentec SA (Eurogentec) Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Kaneka Eurogentec SA (Eurogentec) Main Business and Markets Served
7.6.5 Kaneka Eurogentec SA (Eurogentec) Recent Developments/Updates
7.7 biomers.net GmbH
7.7.1 biomers.net GmbH Locked Nucleic Acids (LNA) Company Information
7.7.2 biomers.net GmbH Locked Nucleic Acids (LNA) Product Portfolio
7.7.3 biomers.net GmbH Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 biomers.net GmbH Main Business and Markets Served
7.7.5 biomers.net GmbH Recent Developments/Updates
7.8 Ella Biotech GmbH
7.8.1 Ella Biotech GmbH Locked Nucleic Acids (LNA) Company Information
7.8.2 Ella Biotech GmbH Locked Nucleic Acids (LNA) Product Portfolio
7.8.3 Ella Biotech GmbH Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Ella Biotech GmbH Main Business and Markets Served
7.8.5 Ella Biotech GmbH Recent Developments/Updates
7.9 Eurofins Genomics LLC
7.9.1 Eurofins Genomics LLC Locked Nucleic Acids (LNA) Company Information
7.9.2 Eurofins Genomics LLC Locked Nucleic Acids (LNA) Product Portfolio
7.9.3 Eurofins Genomics LLC Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Eurofins Genomics LLC Main Business and Markets Served
7.9.5 Eurofins Genomics LLC Recent Developments/Updates
7.10 Azenta Life Sciences
7.10.1 Azenta Life Sciences Locked Nucleic Acids (LNA) Company Information
7.10.2 Azenta Life Sciences Locked Nucleic Acids (LNA) Product Portfolio
7.10.3 Azenta Life Sciences Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Azenta Life Sciences Main Business and Markets Served
7.10.5 Azenta Life Sciences Recent Developments/Updates
7.11 SHIKOKURIKA CO.,LTD
7.11.1 SHIKOKURIKA CO.,LTD Locked Nucleic Acids (LNA) Company Information
7.11.2 SHIKOKURIKA CO.,LTD Locked Nucleic Acids (LNA) Product Portfolio
7.11.3 SHIKOKURIKA CO.,LTD Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 SHIKOKURIKA CO.,LTD Main Business and Markets Served
7.11.5 SHIKOKURIKA CO.,LTD Recent Developments/Updates
7.12 SBS Genetech
7.12.1 SBS Genetech Locked Nucleic Acids (LNA) Company Information
7.12.2 SBS Genetech Locked Nucleic Acids (LNA) Product Portfolio
7.12.3 SBS Genetech Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 SBS Genetech Main Business and Markets Served
7.12.5 SBS Genetech Recent Developments/Updates
7.13 Zhscience
7.13.1 Zhscience Locked Nucleic Acids (LNA) Company Information
7.13.2 Zhscience Locked Nucleic Acids (LNA) Product Portfolio
7.13.3 Zhscience Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Zhscience Main Business and Markets Served
7.13.5 Zhscience Recent Developments/Updates
7.14 Blossom Biotechnologies Inc.
7.14.1 Blossom Biotechnologies Inc. Locked Nucleic Acids (LNA) Company Information
7.14.2 Blossom Biotechnologies Inc. Locked Nucleic Acids (LNA) Product Portfolio
7.14.3 Blossom Biotechnologies Inc. Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.14.4 Blossom Biotechnologies Inc. Main Business and Markets Served
7.14.5 Blossom Biotechnologies Inc. Recent Developments/Updates
7.15 Genecfps
7.15.1 Genecfps Locked Nucleic Acids (LNA) Company Information
7.15.2 Genecfps Locked Nucleic Acids (LNA) Product Portfolio
7.15.3 Genecfps Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.15.4 Genecfps Main Business and Markets Served
7.15.5 Genecfps Recent Developments/Updates
7.16 GenScript
7.16.1 GenScript Locked Nucleic Acids (LNA) Company Information
7.16.2 GenScript Locked Nucleic Acids (LNA) Product Portfolio
7.16.3 GenScript Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.16.4 GenScript Main Business and Markets Served
7.16.5 GenScript Recent Developments/Updates
7.17 RIBO Pharm
7.17.1 RIBO Pharm Locked Nucleic Acids (LNA) Company Information
7.17.2 RIBO Pharm Locked Nucleic Acids (LNA) Product Portfolio
7.17.3 RIBO Pharm Locked Nucleic Acids (LNA) Production, Value, Price, and Gross Margin (2021–2026)
7.17.4 RIBO Pharm Main Business and Markets Served
7.17.5 RIBO Pharm Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Locked Nucleic Acids (LNA) Industry Chain Analysis
8.2 Locked Nucleic Acids (LNA) Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Locked Nucleic Acids (LNA) Production Modes and Processes
8.4 Locked Nucleic Acids (LNA) Sales and Marketing
8.4.1 Locked Nucleic Acids (LNA) Sales Channels
8.4.2 Locked Nucleic Acids (LNA) Distributors
8.5 Locked Nucleic Acids (LNA) Customer Analysis
9 Locked Nucleic Acids (LNA) Market Dynamics
9.1 Locked Nucleic Acids (LNA) Industry Trends
9.2 Locked Nucleic Acids (LNA) Market Drivers
9.3 Locked Nucleic Acids (LNA) Market Challenges
9.4 Locked Nucleic Acids (LNA) Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Locked Nucleic Acids (LNA) Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Locked Nucleic Acids (LNA) Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Locked Nucleic Acids (LNA) Production Capacity (kg) by Manufacturers in 2025
 Table 4. Global Locked Nucleic Acids (LNA) Production by Manufacturers (kg), 2021–2026
 Table 5. Global Locked Nucleic Acids (LNA) Production Market Share by Manufacturers (2021–2026)
 Table 6. Global Locked Nucleic Acids (LNA) Production Value by Manufacturers (US$ Million), 2021–2026
 Table 7. Global Locked Nucleic Acids (LNA) Production Value Share by Manufacturers (2021–2026)
 Table 8. Global Key Players of Locked Nucleic Acids (LNA), Industry Ranking, 2024 vs 2025
 Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Locked Nucleic Acids (LNA) Production Value, 2025
 Table 10. Global Market Locked Nucleic Acids (LNA) Average Price by Manufacturers (US$/g), 2021–2026
 Table 11. Global Key Manufacturers of Locked Nucleic Acids (LNA), Manufacturing Footprints and Headquarters
 Table 12. Global Key Manufacturers of Locked Nucleic Acids (LNA), Product Offerings and Applications
 Table 13. Global Key Manufacturers of Locked Nucleic Acids (LNA), Date of Entry into the Industry
 Table 14. Global Locked Nucleic Acids (LNA) Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Locked Nucleic Acids (LNA) Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Locked Nucleic Acids (LNA) Production Value (US$ Million) by Region (2021–2026)
 Table 18. Global Locked Nucleic Acids (LNA) Production Value Market Share by Region (2021–2026)
 Table 19. Global Locked Nucleic Acids (LNA) Production Value (US$ Million) Forecast by Region (2027–2032)
 Table 20. Global Locked Nucleic Acids (LNA) Production Value Market Share Forecast by Region (2027–2032)
 Table 21. Global Locked Nucleic Acids (LNA) Production Comparison by Region: 2021 vs 2025 vs 2032 (kg)
 Table 22. Global Locked Nucleic Acids (LNA) Production (kg) by Region (2021–2026)
 Table 23. Global Locked Nucleic Acids (LNA) Production Market Share by Region (2021–2026)
 Table 24. Global Locked Nucleic Acids (LNA) Production (kg) Forecast by Region (2027–2032)
 Table 25. Global Locked Nucleic Acids (LNA) Production Market Share Forecast by Region (2027–2032)
 Table 26. Global Locked Nucleic Acids (LNA) Market Average Price (US$/g) by Region (2021–2026)
 Table 27. Global Locked Nucleic Acids (LNA) Market Average Price (US$/g) by Region (2027–2032)
 Table 28. Global Locked Nucleic Acids (LNA) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (kg)
 Table 29. Global Locked Nucleic Acids (LNA) Consumption by Region (kg), 2021–2026
 Table 30. Global Locked Nucleic Acids (LNA) Consumption Market Share by Region (2021–2026)
 Table 31. Global Locked Nucleic Acids (LNA) Forecasted Consumption by Region (kg), 2027–2032
 Table 32. Global Locked Nucleic Acids (LNA) Forecasted Consumption Market Share by Region (2027–2032)
 Table 33. North America Locked Nucleic Acids (LNA) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)
 Table 34. North America Locked Nucleic Acids (LNA) Consumption by Country (kg), 2021–2026
 Table 35. North America Locked Nucleic Acids (LNA) Consumption by Country (kg), 2027–2032
 Table 36. Europe Locked Nucleic Acids (LNA) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)
 Table 37. Europe Locked Nucleic Acids (LNA) Consumption by Country (kg), 2021–2026
 Table 38. Europe Locked Nucleic Acids (LNA) Consumption by Country (kg), 2027–2032
 Table 39. Asia Pacific Locked Nucleic Acids (LNA) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (kg)
 Table 40. Asia Pacific Locked Nucleic Acids (LNA) Consumption by Region (kg), 2021–2026
 Table 41. Asia Pacific Locked Nucleic Acids (LNA) Consumption by Region (kg), 2027–2032
 Table 42. Latin America, Middle East & Africa Locked Nucleic Acids (LNA) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)
 Table 43. Latin America, Middle East & Africa Locked Nucleic Acids (LNA) Consumption by Country (kg), 2021–2026
 Table 44. Latin America, Middle East & Africa Locked Nucleic Acids (LNA) Consumption by Country (kg), 2027–2032
 Table 45. Global Locked Nucleic Acids (LNA) Production (kg) by Type (2021–2026)
 Table 46. Global Locked Nucleic Acids (LNA) Production (kg) by Type (2027–2032)
 Table 47. Global Locked Nucleic Acids (LNA) Production Market Share by Type (2021–2026)
 Table 48. Global Locked Nucleic Acids (LNA) Production Market Share by Type (2027–2032)
 Table 49. Global Locked Nucleic Acids (LNA) Production Value (US$ Million) by Type (2021–2026)
 Table 50. Global Locked Nucleic Acids (LNA) Production Value (US$ Million) by Type (2027–2032)
 Table 51. Global Locked Nucleic Acids (LNA) Production Value Market Share by Type (2021–2026)
 Table 52. Global Locked Nucleic Acids (LNA) Production Value Market Share by Type (2027–2032)
 Table 53. Global Locked Nucleic Acids (LNA) Price (US$/g) by Type (2021–2026)
 Table 54. Global Locked Nucleic Acids (LNA) Price (US$/g) by Type (2027–2032)
 Table 55. Global Locked Nucleic Acids (LNA) Production (kg) by Application (2021–2026)
 Table 56. Global Locked Nucleic Acids (LNA) Production (kg) by Application (2027–2032)
 Table 57. Global Locked Nucleic Acids (LNA) Production Market Share by Application (2021–2026)
 Table 58. Global Locked Nucleic Acids (LNA) Production Market Share by Application (2027–2032)
 Table 59. Global Locked Nucleic Acids (LNA) Production Value (US$ Million) by Application (2021–2026)
 Table 60. Global Locked Nucleic Acids (LNA) Production Value (US$ Million) by Application (2027–2032)
 Table 61. Global Locked Nucleic Acids (LNA) Production Value Market Share by Application (2021–2026)
 Table 62. Global Locked Nucleic Acids (LNA) Production Value Market Share by Application (2027–2032)
 Table 63. Global Locked Nucleic Acids (LNA) Price (US$/g) by Application (2021–2026)
 Table 64. Global Locked Nucleic Acids (LNA) Price (US$/g) by Application (2027–2032)
 Table 65. Ajinomoto Bio-Pharma Locked Nucleic Acids (LNA) Company Information
 Table 66. Ajinomoto Bio-Pharma Locked Nucleic Acids (LNA) Specification and Application
 Table 67. Ajinomoto Bio-Pharma Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 68. Ajinomoto Bio-Pharma Main Business and Markets Served
 Table 69. Ajinomoto Bio-Pharma Recent Developments/Updates
 Table 70. Medtide Inc. Locked Nucleic Acids (LNA) Company Information
 Table 71. Medtide Inc. Locked Nucleic Acids (LNA) Specification and Application
 Table 72. Medtide Inc. Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 73. Medtide Inc. Main Business and Markets Served
 Table 74. Medtide Inc. Recent Developments/Updates
 Table 75. BOC Sciences Locked Nucleic Acids (LNA) Company Information
 Table 76. BOC Sciences Locked Nucleic Acids (LNA) Specification and Application
 Table 77. BOC Sciences Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 78. BOC Sciences Main Business and Markets Served
 Table 79. BOC Sciences Recent Developments/Updates
 Table 80. QIAGEN Locked Nucleic Acids (LNA) Company Information
 Table 81. QIAGEN Locked Nucleic Acids (LNA) Specification and Application
 Table 82. QIAGEN Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 83. QIAGEN Main Business and Markets Served
 Table 84. QIAGEN Recent Developments/Updates
 Table 85. LGC Group Locked Nucleic Acids (LNA) Company Information
 Table 86. LGC Group Locked Nucleic Acids (LNA) Specification and Application
 Table 87. LGC Group Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 88. LGC Group Main Business and Markets Served
 Table 89. LGC Group Recent Developments/Updates
 Table 90. Kaneka Eurogentec SA (Eurogentec) Locked Nucleic Acids (LNA) Company Information
 Table 91. Kaneka Eurogentec SA (Eurogentec) Locked Nucleic Acids (LNA) Specification and Application
 Table 92. Kaneka Eurogentec SA (Eurogentec) Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 93. Kaneka Eurogentec SA (Eurogentec) Main Business and Markets Served
 Table 94. Kaneka Eurogentec SA (Eurogentec) Recent Developments/Updates
 Table 95. biomers.net GmbH Locked Nucleic Acids (LNA) Company Information
 Table 96. biomers.net GmbH Locked Nucleic Acids (LNA) Specification and Application
 Table 97. biomers.net GmbH Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 98. biomers.net GmbH Main Business and Markets Served
 Table 99. biomers.net GmbH Recent Developments/Updates
 Table 100. Ella Biotech GmbH Locked Nucleic Acids (LNA) Company Information
 Table 101. Ella Biotech GmbH Locked Nucleic Acids (LNA) Specification and Application
 Table 102. Ella Biotech GmbH Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 103. Ella Biotech GmbH Main Business and Markets Served
 Table 104. Ella Biotech GmbH Recent Developments/Updates
 Table 105. Eurofins Genomics LLC Locked Nucleic Acids (LNA) Company Information
 Table 106. Eurofins Genomics LLC Locked Nucleic Acids (LNA) Specification and Application
 Table 107. Eurofins Genomics LLC Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 108. Eurofins Genomics LLC Main Business and Markets Served
 Table 109. Eurofins Genomics LLC Recent Developments/Updates
 Table 110. Azenta Life Sciences Locked Nucleic Acids (LNA) Company Information
 Table 111. Azenta Life Sciences Locked Nucleic Acids (LNA) Specification and Application
 Table 112. Azenta Life Sciences Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 113. Azenta Life Sciences Main Business and Markets Served
 Table 114. Azenta Life Sciences Recent Developments/Updates
 Table 115. SHIKOKURIKA CO.,LTD Locked Nucleic Acids (LNA) Company Information
 Table 116. SHIKOKURIKA CO.,LTD Locked Nucleic Acids (LNA) Specification and Application
 Table 117. SHIKOKURIKA CO.,LTD Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 118. SHIKOKURIKA CO.,LTD Main Business and Markets Served
 Table 119. SHIKOKURIKA CO.,LTD Recent Developments/Updates
 Table 120. SBS Genetech Locked Nucleic Acids (LNA) Company Information
 Table 121. SBS Genetech Locked Nucleic Acids (LNA) Specification and Application
 Table 122. SBS Genetech Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 123. SBS Genetech Main Business and Markets Served
 Table 124. SBS Genetech Recent Developments/Updates
 Table 125. Zhscience Locked Nucleic Acids (LNA) Company Information
 Table 126. Zhscience Locked Nucleic Acids (LNA) Specification and Application
 Table 127. Zhscience Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 128. Zhscience Main Business and Markets Served
 Table 129. Zhscience Recent Developments/Updates
 Table 130. Blossom Biotechnologies Inc. Locked Nucleic Acids (LNA) Company Information
 Table 131. Blossom Biotechnologies Inc. Locked Nucleic Acids (LNA) Specification and Application
 Table 132. Blossom Biotechnologies Inc. Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 133. Blossom Biotechnologies Inc. Main Business and Markets Served
 Table 134. Blossom Biotechnologies Inc. Recent Developments/Updates
 Table 135. Genecfps Locked Nucleic Acids (LNA) Company Information
 Table 136. Genecfps Locked Nucleic Acids (LNA) Specification and Application
 Table 137. Genecfps Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 138. Genecfps Main Business and Markets Served
 Table 139. Genecfps Recent Developments/Updates
 Table 140. GenScript Locked Nucleic Acids (LNA) Company Information
 Table 141. GenScript Locked Nucleic Acids (LNA) Specification and Application
 Table 142. GenScript Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 143. GenScript Main Business and Markets Served
 Table 144. GenScript Recent Developments/Updates
 Table 145. RIBO Pharm Locked Nucleic Acids (LNA) Company Information
 Table 146. RIBO Pharm Locked Nucleic Acids (LNA) Specification and Application
 Table 147. RIBO Pharm Locked Nucleic Acids (LNA) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 148. RIBO Pharm Main Business and Markets Served
 Table 149. RIBO Pharm Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Locked Nucleic Acids (LNA) Distributors List
 Table 153. Locked Nucleic Acids (LNA) Customers List
 Table 154. Locked Nucleic Acids (LNA) Market Trends
 Table 155. Locked Nucleic Acids (LNA) Market Drivers
 Table 156. Locked Nucleic Acids (LNA) Market Challenges
 Table 157. Locked Nucleic Acids (LNA) Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Locked Nucleic Acids (LNA)
 Figure 2. Global Locked Nucleic Acids (LNA) Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Locked Nucleic Acids (LNA) Market Share by Type: 2025 vs 2032
 Figure 4. High Affinity LNA Product Picture
 Figure 5. Adjustable LNA Product Picture
 Figure 6. Global Locked Nucleic Acids (LNA) Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Locked Nucleic Acids (LNA) Market Share by Application: 2025 vs 2032
 Figure 8. Basic research
 Figure 9. Clinical diagnosis
 Figure 10. Drug development
 Figure 11. Global Locked Nucleic Acids (LNA) Production Value (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Locked Nucleic Acids (LNA) Production Value (US$ Million), 2021–2032
 Figure 13. Global Locked Nucleic Acids (LNA) Production Capacity (kg), 2021–2032
 Figure 14. Global Locked Nucleic Acids (LNA) Production (kg), 2021–2032
 Figure 15. Global Locked Nucleic Acids (LNA) Average Price (US$/g), 2021–2032
 Figure 16. Locked Nucleic Acids (LNA) Report Years Considered
 Figure 17. Locked Nucleic Acids (LNA) Production Share by Manufacturers in 2025
 Figure 18. Global Locked Nucleic Acids (LNA) Production Value Share by Manufacturers (2025)
 Figure 19. Locked Nucleic Acids (LNA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Top 5 and Top 10 Global Players: Market Share by Locked Nucleic Acids (LNA) Revenue in 2025
 Figure 21. Global Locked Nucleic Acids (LNA) Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Figure 22. Global Locked Nucleic Acids (LNA) Production Value Market Share by Region: 2021 vs 2025 vs 2032
 Figure 23. Global Locked Nucleic Acids (LNA) Production Comparison by Region: 2021 vs 2025 vs 2032 (kg)
 Figure 24. Global Locked Nucleic Acids (LNA) Production Market Share by Region: 2021 vs 2025 vs 2032
 Figure 25. North America Locked Nucleic Acids (LNA) Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 26. Europe Locked Nucleic Acids (LNA) Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 27. China Locked Nucleic Acids (LNA) Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 28. Japan Locked Nucleic Acids (LNA) Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 29. Global Locked Nucleic Acids (LNA) Consumption by Region: 2021 vs 2025 vs 2032 (kg)
 Figure 30. Global Locked Nucleic Acids (LNA) Consumption Market Share by Region: 2021 vs 2025 vs 2032
 Figure 31. North America Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 32. North America Locked Nucleic Acids (LNA) Consumption Market Share by Country (2021–2032)
 Figure 33. U.S. Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 34. Canada Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 35. Europe Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 36. Europe Locked Nucleic Acids (LNA) Consumption Market Share by Country (2021–2032)
 Figure 37. Germany Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 38. France Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 39. U.K. Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 40. Italy Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 41. Russia Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 42. Asia Pacific Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 43. Asia Pacific Locked Nucleic Acids (LNA) Consumption Market Share by Region (2021–2032)
 Figure 44. China Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 45. Japan Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 46. South Korea Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 47. China Taiwan Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 48. Southeast Asia Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 49. India Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 50. Latin America, Middle East & Africa Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 51. Latin America, Middle East & Africa Locked Nucleic Acids (LNA) Consumption Market Share by Country (2021–2032)
 Figure 52. Mexico Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 53. Brazil Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 54. Turkey Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 55. GCC Countries Locked Nucleic Acids (LNA) Consumption and Growth Rate (kg), 2021–2032
 Figure 56. Global Production Market Share of Locked Nucleic Acids (LNA) by Type (2021–2032)
 Figure 57. Global Production Value Market Share of Locked Nucleic Acids (LNA) by Type (2021–2032)
 Figure 58. Global Locked Nucleic Acids (LNA) Price (US$/g) by Type (2021–2032)
 Figure 59. Global Production Market Share of Locked Nucleic Acids (LNA) by Application (2021–2032)
 Figure 60. Global Production Value Market Share of Locked Nucleic Acids (LNA) by Application (2021–2032)
 Figure 61. Global Locked Nucleic Acids (LNA) Price (US$/g) by Application (2021–2032)
 Figure 62. Locked Nucleic Acids (LNA) Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD